ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Over-the-Counter Nasal Antihistamine americanpharmaceuticalreview
June 23, 2021The U.S. FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. -
BM32 vaccine developed against rhinitis europeanpharmaceuticalreview
April 30, 2019Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis… -
Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma
worldpharmanews
November 10, 2018AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal
Pharma Sources Insight July 2025
